Testing effectiveness (Phase 2)Study completedNCT00003478
What this trial is testing
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
Who this might be right for
Brain and Central Nervous System Tumors
Duke University 10